Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

被引：1
作者：
Cochrane, Tara [1 ,2 ]
Campbell, Belinda A. [3 ,4 ,5 ]
Gangatharan, Shane A. [6 ,7 ]
Latimer, Maya [8 ]
Khor, Richard [9 ]
Christie, David R. H. [10 ,11 ]
Gilbertson, Michael [12 ,13 ,14 ]
Ratnasingam, Sumita [15 ]
Palfreyman, Emma [16 ]
Lee, Hui-Peng [17 ]
Trotman, Judith [18 ,19 ]
Hertzberg, Mark [20 ,21 ]
Dickinson, Michael [5 ,22 ,23 ]
机构：
[1] Gold Coast Univ Hosp, Dept Haematol, Gold Coast, Qld, Australia
[2] Griffiths Univ, Sch Med, Gold Coast, Qld, Australia
[3] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Clin Pathol, Parkville, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[6] Fiona Stanley Hosp, Perth, WA, Australia
[7] Univ Western Australia, Perth, WA, Australia
[8] ACT Pathol & Canberra Hosp, Canberra, ACT, Australia
[9] Austin Hosp, Melbourne, Vic, Australia
[10] Genesiscare, Gold Coast, Qld, Australia
[11] Bond Univ, Gold Coast, Qld, Australia
[12] Monash Hlth, Melbourne, Vic, Australia
[13] Monash Univ, Sch Clin Sci, Melbourne, Vic, Australia
[14] Western Hlth, Dept Haematol & Oncol, Melbourne, Vic, Australia
[15] Univ Hosp Geelong, Andrew Love Canc Ctr, Geelong, Vic, Australia
[16] Royal Darwin Hosp, Darwin, NT, Australia
[17] Flinders Med Ctr, Adelaide, SA, Australia
[18] Concord Repatriat Gen Hosp, Sydney, NSW, Australia
[19] Univ Sydney, Sydney, NSW, Australia
[20] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia
[21] Univ NSW, Sydney, NSW, Australia
[22] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[23] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 12期
关键词：
Hodgkin lymphoma; PET adapted; chemotherapy; HL; radiotherapy; BREAST-CANCER RISK; POSITRON-EMISSION-TOMOGRAPHY; ACUTE MYELOID-LEUKEMIA; PRIMARY THYROID-CANCER; RADIATION-THERAPY; CHILDHOOD-CANCER; OPEN-LABEL; BRENTUXIMAB VEDOTIN; ADAPTED TREATMENT; PROGNOSTIC SCORE;
D O I：
10.1111/imj.15503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.
引用
收藏
页码：2119 / 2128
页数：10
相关论文
共 71 条
  • [1] Long-term cause-specific mortality of patients treated for Hodgkin's disease
    Aleman, BMP
    van den Belt-Dusebout, AW
    Klokman, WJ
    van't Veer, MB
    Bartelink, H
    van Leeuwen, FE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) : 3431 - 3439
  • [2] Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
    Andre, Marc P. E.
    Girinsky, Theodore
    Federico, Massimo
    Reman, Oumedaly
    Fortpied, Catherine
    Gotti, Manuel
    Casasnovas, Olivier
    Brice, Pauline
    van der Maazen, Richard
    Re, Alessandro
    Edeline, Veronique
    Ferme, Christophe
    van Imhoff, Gustaaf
    Merli, Francesco
    Bouabdallah, Reda
    Sebban, Catherine
    Specht, Lena
    Stamatoullas, Aspasia
    Delarue, Richard
    Fiaccadori, Valeria
    Bellei, Monica
    Raveloarivahy, Tiana
    Versari, Annibale
    Hutchings, Martin
    Meignan, Michel
    Raemaekers, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1786 - +
  • [3] [Anonymous], 2017, Hematol Oncol, DOI [10.1002/hon.2437_53, DOI 10.1002/HON.2437_53, DOI 10.1002/HON.2437]
  • [4] Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
    Armenian, Saro H.
    Hudson, Melissa M.
    Mulder, Renee L.
    Chen, Ming Hui
    Constine, Louis S.
    Dwyer, Mary
    Nathan, Paul C.
    Tissing, Wim J. E.
    Shankar, Sadhna
    Sieswerda, Elske
    Skinner, Rod
    Steinberger, Julia
    van Dalen, Elvira C.
    van der Pal, Helena
    Wallace, W. Hamish
    Levitt, Gill
    Kremer, Leontien C. M.
    [J]. LANCET ONCOLOGY, 2015, 16 (03) : E123 - E136
  • [5] Australian Institute of Health and Welfare Statistics (AIHW), 2019, STAT ICD 10 C81 REP
  • [6] Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
    Behringer, Karolin
    Goergen, Helen
    Hitz, Felicitas
    Zijlstra, Josee M.
    Greil, Richard
    Markova, Jana
    Sasse, Stephanie
    Fuchs, Michael
    Topp, Max S.
    Soekler, Martin
    Mathas, Stephan
    Meissner, Julia
    Wilhelm, Martin
    Koch, Peter
    Lindemann, Hans-Walter
    Schalk, Enrico
    Semrau, Robert
    Kriz, Jan
    Vieler, Tom
    Bentz, Martin
    Lange, Elisabeth
    Mahlberg, Rolf
    Hassler, Andre
    Vogelhuber, Martin
    Hahn, Dennis
    Mezger, Joerg
    Krause, Stefan W.
    Skoetz, Nicole
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Hallek, Michael
    Borchmann, Peter
    Stein, Harald
    Eich, Hans
    Engert, Andreas
    [J]. LANCET, 2015, 385 (9976) : 1418 - 1427
  • [7] Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
    Behringer, Karolin
    Mueller, Horst
    Goergen, Helen
    Thielen, Indra
    Eibl, Angelika Diana
    Stumpf, Volker
    Wessels, Carsten
    Tz, Martin Wiehlpu
    Rosenbrock, Johannes
    Halbsguth, Teresa
    Reiners, Katrin S.
    Schober, Thomas
    Renno, Jorg H.
    von Wolff, Michael
    van der Ven, Katrin
    Kuehr, Marietta
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 231 - 239
  • [8] Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma
    Bhatt, Vijaya R.
    Giri, Smith
    Verma, Vivek
    Dahal, Sumit
    Shah, Binay K.
    Pathak, Ranjan
    Bociek, R. Gregory
    Vose, Julie M.
    Armitage, James O.
    [J]. FUTURE ONCOLOGY, 2016, 12 (13) : 1565 - 1575
  • [9] Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study
    Bhatti, Parveen
    Veiga, Lene H. S.
    Ronckers, Cecile M.
    Sigurdson, Alice J.
    Stovall, Marilyn
    Smith, Susan A.
    Weathers, Rita
    Leisenring, Wendy
    Mertens, Ann C.
    Hammond, Sue
    Friedman, Debra L.
    Neglia, Joseph P.
    Meadows, Anna T.
    Donaldson, Sarah S.
    Sklar, Charles A.
    Robison, Leslie L.
    Inskip, Peter D.
    [J]. RADIATION RESEARCH, 2010, 174 (06) : 741 - 752
  • [10] The treatment of older Hodgkin lymphoma patients
    Boell, Boris
    Goergen, Helen
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) : 82 - 92
12345678